Teva Recalls FENTANYL Buccal Tablets CII
Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing a labeling error, the U.S. Food and Drug Administration said.
Stay updated with breaking news from Buccal Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing a labeling error, the U.S. Food and Drug Administration said.
The Business Research Company’s Buccal Drug Delivery System Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032
The Global Buccal Drug Delivery Systems Market size was estimated at USD 1,892. 68 million in 2021 and expected to reach USD 2,056. ...
/PRNewswire/ -- Polaris Market Research recently published a research report on "Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis...
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets...